MeSH D007232 - newborn infant diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009358:Hereditary congenital and neonatal diseases and abnormalities
0 Companies
0 Drugs
Success rate
D007232:
Newborn infant diseases
0 Companies
0 Drugs
Success rate
D000071074:Neonatal sepsis
0 Companies
0 Drugs
Success rate
D000080984:Congenital bone marrow failure syndromes
0 Companies
0 Drugs
Success rate
D000652:Amniotic band syndrome
0 Companies
0 Drugs
Success rate
D000751:Neonatal anemia
0 Companies
0 Drugs
Success rate
D001238:Asphyxia neonatorum
0 Companies
0 Drugs
Success rate
D001720:Birth injuries
0 Companies
0 Drugs
Success rate
D003085:Colic
0 Companies
0 Drugs
Success rate
D003550:Cystic fibrosis
D004899:Fetal erythroblastosis
0 Companies
0 Drugs
Success rate
D006475:Vitamin k deficiency bleeding
0 Companies
0 Drugs
Success rate
D006554:Umbilical hernia
0 Companies
0 Drugs
Success rate
D006871:Hydrophthalmos
0 Companies
0 Drugs
Success rate
D006958:Cortical hyperostosis congenital
0 Companies
0 Drugs
Success rate
D007057:Ichthyosis
0 Companies
0 Drugs
Success rate
D007235:Premature infant diseases
0 Companies
0 Drugs
Success rate
D008471:Meconium aspiration syndrome
0 Companies
0 Drugs
Success rate
D009357:Neonatal abstinence syndrome
0 Companies
0 Drugs
Success rate
D009878:Ophthalmia neonatorum
0 Companies
0 Drugs
Success rate
D011038:Rothmund-thomson syndrome
0 Companies
0 Drugs
Success rate
D012593:Sclerema neonatorum
0 Companies
0 Drugs
Success rate
D013590:Congenital syphilis
0 Companies
0 Drugs
Success rate
D013796:Thanatophoric dysplasia
0 Companies
0 Drugs
Success rate
D014125:Congenital toxoplasmosis
0 Companies
0 Drugs
Success rate
D015223:Wolman disease
0 Companies
0 Drugs
Success rate
D020331:Mobius syndrome
0 Companies
0 Drugs
Success rate
D020417:Congenital nystagmus
0 Companies
0 Drugs
Success rate
D044903:Congenital hyperinsulinism
0 Companies
0 Drugs
Success rate
D051556:Neonatal hyperbilirubinemia
0 Companies
0 Drugs
Success rate
D054098:Neonatal alloimmune thrombocytopenia
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
50%2/4
Phase 3
0%0/13
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use